{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:21:09Z","timestamp":1759134069927},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174268","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T17:32:52Z","timestamp":1492709572000},"page":"e0174268","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC"],"prefix":"10.1371","volume":"12","author":[{"given":"Vishesh","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud P.","family":"Coroller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen B.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott J.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon O.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo J. W. L.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond H.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1200\/JCO.2014.59.2360","article-title":"Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline","volume":"33","author":"A Bezjak","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ejcts\/ezu270","article-title":"Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer","volume":"47","author":"PJ Speicher","year":"2015","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","article-title":"Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805","volume":"13","author":"KS Albain","year":"1995","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/S0003-4975(00)01585-X","article-title":"Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival","volume":"70","author":"R Bueno","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"DC Betticher","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/jso.20644","article-title":"Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935","volume":"94","author":"MT Jaklitsch","year":"2006","journal-title":"J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer","volume":"99","author":"JP van Meerbeeck","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1470-2045(08)70156-6","article-title":"Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer","volume":"9","author":"M Thomas","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijrobp.2011.11.069","article-title":"Radiation therapy oncology group protocol 02\u201329: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung","volume":"84","author":"M Suntharalingam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0169-5002(03)00245-9","article-title":"The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer","volume":"42","author":"N Sawabata","year":"2003","journal-title":"Lung Cancer Amst Neth"},{"key":"ref12","first-page":"120","article-title":"Significance of the number of positive lymph nodes in resected non-small cell lung cancer","volume":"1","author":"T Fukui","year":"2006","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ijrobp.2007.07.2323","article-title":"Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy","volume":"70","author":"C Dehing-Oberije","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1378\/chest.12-0750","article-title":"A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer","volume":"143","author":"H Saji","year":"2013","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ijrobp.2009.12.060","article-title":"Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy","volume":"79","author":"BM Alexander","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2005.07.967","article-title":"Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume","volume":"64","author":"K Basaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref17","first-page":"573","article-title":"Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer","volume":"20","author":"D Arslan","year":"2015","journal-title":"J BUON Off J Balk Union Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","article-title":"Survival of Patients With Resected N2 Non\u2013Small-Cell Lung Cancer: Evidence for a Subclassification and Implications","volume":"18","author":"F Andre","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1758834011401951","article-title":"Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables","volume":"3","author":"T Berghmans","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"ref20","first-page":"228","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.athoracsur.2007.08.020","article-title":"Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival","volume":"85","author":"JG Lee","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.lungcan.2005.11.008","article-title":"Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy","volume":"52","author":"TE Stinchcombe","year":"2006","journal-title":"Lung Cancer Amst Neth"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1245\/s10434-012-2800-x","article-title":"Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery","volume":"20","author":"A Amini","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer","volume":"10","author":"H Asamura","year":"2015","journal-title":"J Thorac Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.2008.21.7810","article-title":"Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study","volume":"28","author":"G Friedel","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"KS Albain","year":"2009","journal-title":"Lancet"},{"key":"ref28","first-page":"1528","article-title":"18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy","volume":"54","author":"EA Usmanij","year":"2013","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv004","article-title":"Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668\/RTOG 0235","volume":"107","author":"N Ohri","year":"2015","journal-title":"J Natl Cancer Inst"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T17:59:21Z","timestamp":1719165561000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174268"}},"subtitle":[],"editor":[{"given":"Hyun-Sung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174268","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}